CLDX vs PNC · rev $37.0K vs P/E 14, rev $6.88B
Celldex Therapeutics Inc (CLDX) versus PNC Financial Services Group Inc (PNC) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
PNC Financial Services Group Inc (PNC) is a banks - regional company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported PNC revenue for 2026-06-30 was $6.88B. Net income was $2.04B. Revenue was up 11.5% from 2026-03-31 to 2026-06-30. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
CLDX currently screens at market cap $2.35B. PNC currently screens at market cap $77.76B and trailing P/E 13.9.
Not investment advice. Open the CLDX and PNC stock pages for the full models.
Not investment advice.